It is a pharma private limited company based in Kalyan, Maharashtra, India, established in 2018.
2018 | Kalyan, Maharashtra, India | ActiveSoley Pharmaceutical Private Limited, a active private limited company, was established on 19 September 2018 in Kalyan, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239MH2018PTC314218. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Rehan Ejaz Khan (Director), Sohail Masoom Khan (Director), Faizan Khan Razzaque (Director). Past directors included Manoj Uttam Salve, Dinesh Siddhinath Shukla, Renu Rampratap Pandey. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No 44, Lane No 11, Hamal Wadi Bunder Road, Kalyan, Maharashtra, 421301.
U24239MH2018PTC314218
314218
19 September 2018
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Soley Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rehan Ejaz Khan | Director | 29 Nov 2021 | Current |
| Sohail Masoom Khan | Director | 29 Nov 2021 | Current |
| Faizan Khan Razzaque | Director | 29 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jan 2022 | Past |
| Pramod Abcsdd | Director | 03 Jul 2019 | Past |
| Pramod Abcsdd | Director | 13 Jan 2022 | Past |
| Pramod Abcsdd | Director | 13 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 13 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Soley Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.78% increase. The company also saw a substantial fall in profitability, with a 16254.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Soley Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Soley Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Soley Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soley Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Soley Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Soley Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Rehan Ejaz Khan was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 4 years 24 days . was documented.
The activity Sohail Masoom Khan was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 4 years 24 days . was completed.
Faizan Khan Razzaque was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 4 years 24 days . was recorded as a recent event.
Soley Pharmaceutical Private Limited was registered on 19 Sep 2018 with Roc Mumbai & aged 7 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Soley Pharmaceutical Private Limited is U24239MH2018PTC314218.
Soley Pharmaceutical Private Limited is headquartered at H No 44, Lane No 11, Hamal Wadi Bunder Road, Kalyan, Maharashtra, 421301.
Soley Pharmaceutical Private Limited was incorporated on 19 September 2018.
The current directors of Soley Pharmaceutical Private Limited are
The primary industry of Soley Pharmaceutical Private Limited is Pharma.
Soley Pharmaceutical Private Limited is unlisted.
The authorized capital of Soley Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX